Antimalarial Drug Screening (Projects)
performed by Medicines for Malaria Venture in 2009 and showed that OZ439 is well tolerated at all dose levels. So called 'proof of concept' phase II clinical trials with malaria patients showed that the [...] Our mandate with Medicines for Malaria Venture in Geneva comprises exploratory work on novel compounds from various sources. The goal is to identify novel chemical entities showing antimalarial activity [...] during the last decade is that such novel compounds can ultimately become part of...
Sergio Wittlin (People)
Professional activities at Swiss TPH Head of Malaria Drug Discovery Group sponsored by the non-profit organization Medicines for Malaria Venture (MMV) Higher education and qualifications
WHO TVC (Projects)
Increasing coverage of malaria vector control interventions globally has led to significant reductions in disease burden. However due to its high recurrent cost, there is a need to determine if and when [...] reduced. We conduct literature reviews and simulate a mathematical model of Plasmodium falciparum malaria epidemiology to determine the impact of scaling back vector control on transmission and disease.
Luis Segura (People)
by The Global Fund in the Americas, Africa, and South East Asia regions. He also has led a large malaria program in Equatorial Guinea, which in addition to communicational interventions, vector control [...] technical and logistic support to case management, included clinical trials of a sporozoite based malaria vaccine. His experience includes also operational research and monitoring of maternal-child and
Further development of simulations of Plasmodium falciparum interventions and their integration with the needs of stakeholders (Projects)
platform for comparing, fitting, and evaluating different individual-based stochastic simulations of malaria epidemiology. Aims In the next phase of the project, we propose to exploit the functionality [...] potential clients, and develop capacity to anticipate and react promptly to requests from the R & D and malaria intervention communities.
Ingrid Felger (People)
Senior Lecturer in Molecular Parasitology Main Research Fields: Molecular epidemiology (malaria, HIV), molecular diagnostics (parasitic diseases)
RBM Working Groups (Projects)
for the travel support of affected-country participants to the annual meetings of the Roll Back Malaria Working Groups (Vector Control, Case Management, Multisectoral Approach).